Anne Prøven

1.3k total citations
20 papers, 944 citations indexed

About

Anne Prøven is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Anne Prøven has authored 20 papers receiving a total of 944 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Immunology. Recurrent topics in Anne Prøven's work include Spondyloarthritis Studies and Treatments (6 papers), Urticaria and Related Conditions (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Anne Prøven is often cited by papers focused on Spondyloarthritis Studies and Treatments (6 papers), Urticaria and Related Conditions (4 papers) and Rheumatoid Arthritis Research and Therapies (4 papers). Anne Prøven collaborates with scholars based in Norway, United States and Sweden. Anne Prøven's co-authors include W. Michael O’Fallon, Sherine E. Gabriel, Carlos H. Orces, Gene G. Hunder, Glenn Haugeberg, G G Hunder, S. E. Gabriel, Øyvind Palm, Gudrun Rohde and Dan Nordström and has published in prestigious journals such as Gut, Annals of the Rheumatic Diseases and Mayo Clinic Proceedings.

In The Last Decade

Anne Prøven

20 papers receiving 926 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Prøven Norway 12 561 550 207 158 150 20 944
Jolanta Dadonienė Lithuania 14 716 1.3× 929 1.7× 328 1.6× 201 1.3× 102 0.7× 50 1.5k
H. Devilliers France 17 637 1.1× 405 0.7× 96 0.5× 209 1.3× 115 0.8× 69 990
Alberto Floris Italy 16 608 1.1× 221 0.4× 98 0.5× 262 1.7× 77 0.5× 51 854
P.Y. Hatron France 19 487 0.9× 458 0.8× 117 0.6× 158 1.0× 69 0.5× 46 1.3k
Susan Lester Australia 14 308 0.5× 254 0.5× 103 0.5× 99 0.6× 50 0.3× 30 681
Karina A. Keogh United States 18 899 1.6× 1.3k 2.4× 361 1.7× 199 1.3× 64 0.4× 39 1.7k
J Hollywood United Kingdom 5 653 1.2× 1.1k 2.1× 390 1.9× 178 1.1× 36 0.2× 9 1.3k
S Yurdakul Türkiye 16 696 1.2× 852 1.5× 102 0.5× 90 0.6× 91 0.6× 31 1.6k
Claudia Metzler Germany 10 581 1.0× 723 1.3× 148 0.7× 111 0.7× 32 0.2× 16 878
V Kyle United Kingdom 16 794 1.4× 867 1.6× 436 2.1× 94 0.6× 29 0.2× 25 1.2k

Countries citing papers authored by Anne Prøven

Since Specialization
Citations

This map shows the geographic impact of Anne Prøven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Prøven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Prøven more than expected).

Fields of papers citing papers by Anne Prøven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Prøven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Prøven. The network helps show where Anne Prøven may publish in the future.

Co-authorship network of co-authors of Anne Prøven

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Prøven. A scholar is included among the top collaborators of Anne Prøven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Prøven. Anne Prøven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kjeken, Ingvild, et al.. (2021). Task shifting in the care for patients with hand osteoarthritis. Protocol for a randomized controlled non-inferiority trial. BMC Musculoskeletal Disorders. 22(1). 194–194. 4 indexed citations
2.
3.
Rohde, Gudrun, et al.. (2019). Sexual Quality of Life in Patients with Axial Spondyloarthritis in the Biologic Treatment Era. The Journal of Rheumatology. 46(9). 1075–1083. 9 indexed citations
4.
5.
Rohde, Gudrun, et al.. (2017). The relationship between demographic- and disease-related variables and health-related quality of life in patients with axial spondyloarthritis. BMC Musculoskeletal Disorders. 18(1). 328–328. 20 indexed citations
6.
7.
8.
Theander, Elke, et al.. (2015). FRI0163 Smoking Status Does not Seem to Affect Tocilizumab Efficacy in RA Patients. Annals of the Rheumatic Diseases. 74. 482–482. 8 indexed citations
9.
Haugeberg, Glenn, et al.. (2014). Generalized bone loss in early rheumatoid arthritis patients followed for ten years in the biologic treatment era. BMC Musculoskeletal Disorders. 15(1). 289–289. 41 indexed citations
10.
Gunnarsson, Ragnar, Øyvind Molberg, Åse Stavland Lexberg, et al.. (2013). Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Lara D. Veeken. 52(7). 1208–1213. 51 indexed citations
11.
Nordström, Dan, Ann Knight, Reijo Luukkainen, et al.. (2012). Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still’s Disease. An Open, Randomized, Multicenter Study. The Journal of Rheumatology. 39(10). 2008–2011. 115 indexed citations
12.
Gunnarsson, Ragnar, Trond Mogens Aaløkken, Øyvind Molberg, et al.. (2012). Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study. Annals of the Rheumatic Diseases. 71(12). 1966–1972. 69 indexed citations
13.
14.
Leckie, Pamela, et al.. (2009). 'OUT-PATIENT' ALBUMIN DIALYSIS FOR INTRACTABLE ITCH IN CHRONIC CHOLESTATIC LIVER DISEASE PATIENTS IS A FEASIBLE, SAFE AND EFFICACIOUS ALTERNATIVE TO LIVER TRANSPLANTATION. UCL Discovery (University College London). 1 indexed citations
15.
Kvien, Tore K, Eirik Fjeld, B. Slatkowsky-Christensen, et al.. (2007). Efficacy and safety of a novel synergistic drug candidate, CRx-102, in hand osteoarthritis. Annals of the Rheumatic Diseases. 67(7). 942–948. 51 indexed citations
16.
Kvien, Tore K, B. Slatkowsky-Christensen, Eirik Fjeld, et al.. (2006). P217 THE RESPONSIVENESS OF JOINT COUNTS AND PATIENT-REPORTED MEASURES IN HAND OSTEOARTHRITIS (HOA): ANALYSES FROM A PLACEBO-CONTROLLED RANDOMIZED CLINICAL TRIAL (RCT). Osteoarthritis and Cartilage. 14. S121–S122. 1 indexed citations
17.
Prøven, Anne, Kevin G. Moder, April Chang‐Miller, et al.. (2004). Clinical Importance of Positive Test Results for Lupus Anticoagulant and Anticardiolipin Antibodies. Mayo Clinic Proceedings. 79(4). 467–475. 19 indexed citations
18.
Prøven, Anne, Sherine E. Gabriel, Carlos H. Orces, W. Michael O’Fallon, & Gene G. Hunder. (2003). Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes. Arthritis Care & Research. 49(5). 703–708. 437 indexed citations
19.
Prøven, Anne, S. E. Gabriel, W. Michael O’Fallon, & G G Hunder. (1999). Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis.. PubMed. 26(6). 1333–7. 49 indexed citations
20.
Bekkelund, Svein Ivar, Svein Ivar Mellgren, Anne Prøven, & Gunnar Husby. (1995). QUANTIFIED NEUROLOGICAL EXAMINATION WITH EMPHASIS ON MOTOR AND SENSORY FUNCTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND CONTROLS. Lara D. Veeken. 35(11). 1116–1121. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jolanta Dadonienė Breakdown of academic impact, for papers by H. Devilliers Breakdown of academic impact, for papers by Alberto Floris Breakdown of academic impact, for papers by P.Y. Hatron Breakdown of academic impact, for papers by Susan Lester Breakdown of academic impact, for papers by Karina A. Keogh Breakdown of academic impact, for papers by J Hollywood Breakdown of academic impact, for papers by S Yurdakul Breakdown of academic impact, for papers by Claudia Metzler Breakdown of academic impact, for papers by V Kyle
Rankless by CCL
2026